Extract from the Register of European Patents

EP About this file: EP0150309

EP0150309 - Hybridoma antibody [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  05.10.1993
Database last updated on 11.04.2026
Most recent event   Tooltip05.10.1993Opposition rejectedpublished on 24.11.1993 [1993/47]
Applicant(s)For all designated states
BOEHRINGER MANNHEIM GMBH
D-68298 Mannheim / DE
[1985/32]
Inventor(s)01 / Naujoks, Kurt Walter, Dr. rer. nat.
Hiltlstrasse 15
D-8035 Gauting / DE
02 / Gerhardt, Willie, Dr. med.
Hallandsgatan 9
S-25252 Helsingborg / SE
03 / Hübner-Parajsz, Christa, Dr. rer. nat.
Marienstrasse 11
D-8132 Tutzing / DE
04 / Wulff, Karl, Dr. rer. nat.
Pütrichstrasse 18
D-8120 Weilheim / DE
05 / Jungfer, Herbert, Dr. med.
Beringerweg 10
D-8132 Tutzing / DE
06 / Lenz, Helmut, Dr. rer. nat.
Waldschmidtstrasse 7
D-8132 Tutzing / DE
07 / Albert, Winfried, Dr. phil.
Moosstrasse 10
D-8121 Pähl / DE
08 / Wahlefeld, August Wilhelm, Dr. rer. nat.
Alpenblickstrasse 25
D-8126 Hohenpeissenberg / DE
[1985/32]
Representative(s)Huber, Bernhard, et al
Patentanwälte H. Weickmann, Dr. K. Fincke F.A. Weickmann, B. Huber Dr. H. Liska, Dr. J. Prechtel, Dr. B. Böhm Postfach 86 08 20
D-81635 München / DE
[N/P]
Former [1985/32]Huber, Bernhard, Dipl.-Chem., et al
Patentanwälte H. Weickmann, Dr. K. Fincke F.A. Weickmann, B. Huber Dr. H. Liska, Dr. J. Prechtel, Dr. B. Böhm Postfach 86 08 20
D-81635 München / DE
Application number, filing date84114172.423.11.1984
[1985/32]
Priority number, dateDE1983334273625.11.1983         Original published format: DE 3342736
[1985/32]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP0150309
Date:07.08.1985
Language:DE
[1985/32]
Type: A3 Search report 
No.:EP0150309
Date:21.08.1985
Language:DE
[1985/34]
Type: B1 Patent specification 
No.:EP0150309
Date:28.06.1989
Language:DE
[1989/26]
Search report(s)(Supplementary) European search report - dispatched on:EP20.06.1985
ClassificationIPC:G01N33/573, G01N33/577, C12Q1/40, // C12P21/00, C12N15/00, C12N5/00
[1985/32]
CPC:
C12Q1/40 (EP,US); G01N33/573 (EP,US); Y10S435/962 (EP,US);
Y10S436/824 (EP,US); Y10S436/828 (EP,US); Y10S530/808 (EP,US);
Y10S530/809 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1985/32]
TitleGerman:Hybridoma-Antikörper[1985/32]
English:Hybridoma antibody[1985/32]
French:Anticorps hybridome[1985/32]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure23.11.1984Examination requested  [1985/32]
23.04.1987Despatch of a communication from the examining division (Time limit: M04)
19.06.1987Reply to a communication from the examining division
02.03.1988Despatch of a communication from the examining division (Time limit: M04)
20.06.1988Reply to a communication from the examining division
27.09.1988Despatch of communication of intention to grant (Approval: No)
21.12.1988Despatch of communication of intention to grant (Approval: later approval)
04.01.1989Communication of intention to grant the patent
04.04.1989Fee for grant paid
04.04.1989Fee for publishing/printing paid
Opposition(s)Opponent(s)01  28.03.1990  22.05.1990  ADMISSIBLE
Genzyme Corporation
75 Kneeland Street Boston
Massachusetts 02111 / US
Opponent's representative
Froud, Clive
Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks
Kent TN13 1XR / GB
 [N/P]
Former [1990/21]
Opponent(s)01  28.03.1990  22.05.1990  ADMISSIBLE
Genzyme Corporation
75 Kneeland Street Boston
Massachusetts 02111 / US
Opponent's representative
Froud, Clive
Elkington and Fife Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
25.05.1990Invitation to proprietor to file observations on the notice of opposition
11.12.1990Reply of patent proprietor to notice(s) of opposition
20.12.1991Despatch of a communication from the opposition division (Time limit: M04)
28.04.1992Reply to a communication from the opposition division
20.04.1993Date of oral proceedings
25.06.1993Despatch of minutes of oral proceedings
25.06.1993Date of despatch of rejection of opposition
05.07.1993Legal effect of rejection of opposition [1993/47]
Fees paidRenewal fee
12.11.1986Renewal fee patent year 03
19.11.1987Renewal fee patent year 04
22.11.1988Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X] JP58183098  
 [X]   PATENTS ABSTRACTS OF JAPAN, Band 8, Nr. 15 (C-206)[1452], 21. Januar 1984; & JP-A-58 183 098 (WAKO JUNYAKU KOGYO K.K.) 26.10.1983 [X]
 [A]   CLINICAL CHEMISTRY, Band 28, Nr. 11, November 1982, Seiten 2201-2205, Washington, US; E.-O. HGELE u.a.: "Mechanism of action of human pancreatic and salivary alpha-amylase on alpha-4-nitrophenyl maltoheptaoside substrate" [A]
 [A]   CLINICAL CHEMISTRY, Band 25, Nr. 3, Mrz 1979, Seiten 481-483, Easton, Pennsylvania, US; K.J. WHITLOW u.a.: "Maltotetraose as a substrate for enzyme-coupled assay of amylase activity in serum and urine" [A]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.